Vaxart, Inc. (NASDAQ:VXRT) Q2 2023 Earnings Call Transcript

Unidentified Analyst: Thank you. I think that’s all from us. Thanks.

Operator: There are no further audio questions at this time. I’d like to turn the call back over to your host, Brant Biehn.

Brant Biehn: Thanks very much. So we had a lot of questions that had been sent in previously ahead of time on various channels. I think most of those have now been asked between Charles and Mayank. So I’m going to — here’s one that I don’t think has been answered completely yet. James, this one’s coming to you. Do you see any accelerated path to commercialization such as EUA, or a smaller Phase 3 study for norovirus? And what’s a realistic timeline to commercialization? James?

James Cummings: Fair enough. Thanks, Brant. So we continue to address the potential options and the timing for commercialization once we have more visibility informed by these study results that we’re just discussing now. Based on those results, those data and interactions with regulatory agencies, we will determine the best plan and timeline for commercialization.

Brant Biehn: That’s fantastic, James. Thanks. And another one I don’t think we hit on during the call and James this is also going to be for you. Please remind us what you’re looking for in the infant study and potential implications for your norovirus program. James?

James Cummings: Sure. Thank you. So it’s unknown how norovirus infectivity and spread would be impacted or affected by a vaccine. As I mentioned, there’s no currently approved vaccine against norovirus. However, there are some studies that suggest that if you vaccinate children, you can also improve the health of adults. You might not be able to protect against all illness, but we know that children acquire disease and can infect their families. So that’s one of the pieces we’re looking at.

Brant Biehn: Fantastic. Thanks, James. So that’s the majority of the other norovirus questions have been asked already and answered by you. So thank you so much for that. I think investors and people on the line that have further questions can take a look at our fireside chat platform on the Investor section of our website and to go ahead and post additional questions. And we’ll follow up at a fireside chat meeting in the near future and answer those questions. So at this point, we’ll close the meeting. Thank you.

Operator: This concludes today’s conference and webcast. You may disconnect your lines at this time, and we thank you for your participation.